Does High Blood Pressure Medicine Cause Gout?

Certain blood pressure medications do raise uric acid levels and increase the likelihood of developing gout, but the effect varies sharply by drug class. Diuretics, commonly called “water pills,” are the biggest offenders, while some other antihypertensives actually lower uric acid and may protect against gout. The picture gets more complicated when you factor in that high blood pressure itself is independently linked to gout risk, so untangling the drug’s effect from the disease’s effect takes some care.

Which Blood Pressure Drugs Raise Gout Risk

Not all antihypertensives are equal when it comes to uric acid. A large population-based case-control study of people with hypertension found strikingly different gout risks depending on the drug class. Diuretics carried the highest risk, roughly doubling it. Beta-blockers raised risk by about half. ACE inhibitors and non-losartan ARBs (angiotensin receptor blockers) showed modest increases. Meanwhile, calcium channel blockers and the specific ARB losartan were associated with reduced risk.¹

That range matters. If you’re taking a calcium channel blocker for your blood pressure, worrying about gout from it is misplaced. If you’re on a thiazide diuretic and you start getting painful joints, the connection is real and worth discussing with your doctor.

Diuretics Are the Primary Culprits

Diuretics work by making your kidneys excrete more sodium and water, which lowers blood volume and blood pressure. But the same kidney mechanism that dumps sodium also affects how your body handles uric acid. Common diuretics elevate uric acid levels by boosting net uric acid reabsorption in a specific part of the kidney’s filtration system.² In plain terms, the drug causes your kidneys to reclaim uric acid that would normally leave the body in urine. That extra uric acid builds up in the blood and, in susceptible people, eventually crystallizes in joints.

The data across different types of diuretics is consistent. In a large cohort of adults with hypertension, using any diuretic was associated with roughly a 50 percent higher risk of developing gout. Loop diuretics, the more powerful variety often prescribed for heart failure, carried the steepest increase at about 2.3 times the risk. Thiazide diuretics, the most commonly prescribed type for blood pressure alone, showed a smaller but still meaningful increase.³ A separate case-control study found even sharper distinctions: loop diuretics carried about 2.6 times the risk compared with past use, thiazide diuretics about 1.7 times, and thiazide-like diuretics about 2.3 times. Potassium-sparing diuretics were the exception, showing no significant increase.⁴

An analysis of the FDA’s adverse event reporting system confirmed that gout-related signals appeared across a wide range of individual diuretics, including furosemide, bumetanide, hydrochlorothiazide, indapamide, chlorthalidone, and spironolactone, among others.⁵ If you see “diuretic” or “water pill” on your medication list, the gout connection applies regardless of the specific brand name.

One nuance worth noting: among the two most commonly prescribed thiazides, chlorthalidone and hydrochlorothiazide, gout risk appears similar. A comparative study found new-onset gout in about 1.3 to 1.7 percent of patients taking either drug over a follow-up period, with no statistically significant difference between them.⁶ If your doctor is choosing between these two, gout risk isn’t a reason to prefer one over the other.

Dose Matters More Than People Realize

The gout risk from thiazide diuretics is not an all-or-nothing phenomenon. Research has found that doses of 25 mg per day or higher (in hydrochlorothiazide equivalents) were significantly associated with an increased need for gout treatment, while lower doses did not carry the same risk.⁷ This is a practical finding because many people with mild hypertension are prescribed low-dose thiazides, sometimes as little as 12.5 mg. At those doses, the uric acid impact may be modest enough to stay below the threshold that triggers crystal formation.

For people already on higher doses, a conversation about dose reduction might be productive. Current guidelines for hypertension have generally trended toward lower diuretic doses combined with other agents, partly because of side effects like this one. The goal is controlling blood pressure without pushing uric acid into dangerous territory.

Beta-Blockers and the Overlooked Risk

Diuretics get most of the attention in the gout conversation, but beta-blockers deserve a mention. The population-based study cited earlier found beta-blocker use associated with about a 48 percent higher gout risk in people with hypertension.¹ That’s smaller than the diuretic effect but not trivial.

The evidence isn’t uniform across all beta-blockers, though. Metoprolol, one of the most commonly prescribed, raised uric acid levels and increased gout-related outcomes in a trial of African American adults with chronic kidney disease. Compared to ramipril (an ACE inhibitor), metoprolol raised uric acid by about 0.4 mg/dL and significantly increased gout-related medical encounters.⁸ But a secondary analysis of the large ALLHAT trial found that atenolol, another common beta-blocker, was not significantly associated with gout risk.⁹ So this class may not be uniformly problematic, and the risk may depend on which specific beta-blocker you’re taking and what other health conditions you have.

Blood Pressure Drugs That Protect Against Gout

The story isn’t all bad news. Two classes of blood pressure medication are consistently linked with lower gout risk, and understanding them gives you and your doctor a real option when gout is a concern.

Losartan Stands Alone Among ARBs

Losartan is unique among blood pressure medications in that it actively lowers uric acid. It does this by blocking uric acid reabsorption in the kidney, functioning as a mild uricosuric agent alongside its blood-pressure-lowering action. Clinical guidelines specifically recommend losartan for hypertensive patients with gout because of this dual benefit.¹⁰ In one study, losartan lowered serum uric acid from roughly 7.0 mg/dL to about 5.9 mg/dL, and the effect was similar whether the dose was once or twice daily.¹¹

This property belongs to losartan specifically, not to its drug class. Irbesartan, candesartan, and other ARBs don’t share the uricosuric effect. In fact, non-losartan ARBs were associated with a modest increase in gout risk in population data.¹ So if you’re on an ARB and concerned about gout, the answer isn’t “ARBs are fine.” The answer is that losartan is the one that helps.

Calcium Channel Blockers

Calcium channel blockers, particularly the dihydropyridine type like amlodipine and nifedipine, are associated with reduced uric acid levels and lower gout risk. A study of dihydropyridine calcium channel blockers found that treatment was associated with reduced serum uric acid, especially when blood pressure was well controlled.¹²

The ALLHAT trial provided some of the clearest head-to-head comparisons. Over about five years, amlodipine had the lowest gout incidence at roughly 1.6 per 100 person-years, compared to 2.5 for chlorthalidone (a diuretic) and 1.9 for lisinopril (an ACE inhibitor). Amlodipine reduced gout risk by about 37 percent compared to chlorthalidone during the trial period.⁹ For someone who needs blood pressure medication and has gout or elevated uric acid, a calcium channel blocker is a sensible choice that avoids adding to the problem.

Is It the Drug or the Disease?

Here’s the part that often gets left out: high blood pressure itself is linked to higher uric acid and gout, independent of any medication. A Mendelian randomization study, which uses genetic variants to tease apart cause from correlation, found a significant causal relationship between hypertension and gout risk. The same study did not find causal effects for the specific antihypertensives it examined (candesartan, lisinopril, and ramipril), suggesting that at least for some drug classes, the gout risk people attribute to their medication may really be the underlying disease at work.¹³

This fits with an observation from the ARIC cohort study: after statistically adjusting for serum uric acid levels, the association between diuretic use and gout disappeared entirely.³ In other words, diuretics raise gout risk because they raise uric acid. If uric acid stays controlled, the drug itself doesn’t seem to cause gout through some other pathway. This is both reassuring and practically useful: it means managing uric acid levels directly can mitigate the risk even if you can’t switch off a diuretic.

Kidney function is another confounding factor. Most uric acid leaves the body through the kidneys, and an estimated 85 to 90 percent of gout cases stem from poor kidney disposal of urate. People prescribed diuretics often already have conditions that impair kidney function, such as heart failure or chronic kidney disease. Some researchers have argued that gout in diuretic users may depend more on the underlying condition requiring the diuretic than on the drug itself.¹

When You Already Have Gout and Need Blood Pressure Medication

For people who already carry a gout diagnosis, the choice of antihypertensive becomes even more consequential. Diuretic use combined with alcohol intake was associated with higher risk of recurrent gout attacks in a case-crossover study, and the effect of purine-rich foods on gout flares persisted whether or not patients were taking diuretics.¹⁴¹⁵ In other words, diuretics don’t just trigger a first episode. They keep contributing to recurrence, and dietary triggers stack on top of the drug effect.

If you can’t avoid diuretics entirely, urate-lowering therapy with drugs like allopurinol or febuxostat can partially compensate. One study of gout patients found that those taking diuretics alongside allopurinol had a harder time reaching the most aggressive uric acid target (below 5 mg/dL), though they could still reach higher targets. The study did not find that diuretics required significantly higher doses of urate-lowering medication after accounting for other factors.¹⁶ So diuretics make gout management harder but not impossible.

Expert opinion favors losartan as a first-line choice for hypertensive patients who also have gout, given its unique uricosuric properties.¹⁷ If losartan alone doesn’t control blood pressure, adding a calcium channel blocker gives you a combination that addresses hypertension from two angles while keeping uric acid neutral or lower. Only when those options are inadequate should diuretics be considered, and if they are, uric acid monitoring and urate-lowering therapy may be warranted.

Genetics Add Another Layer

Not everyone on a diuretic gets gout, and the reason partly comes down to your genes. Research from the ARIC cohort found a significant interaction between diuretic use and variants in specific uric acid transport genes. Variants in SLC22A11 and SLC2A9, which encode transporters involved in how the kidney handles uric acid, modified the gout risk from diuretics. People with certain variants of these transporter genes were more susceptible to diuretic-induced uric acid elevation.¹⁸

This makes intuitive sense. Diuretics affect the same kidney transport systems that genetically vary between individuals. If your transporter genes are already on the less-efficient end, adding a drug that further impairs uric acid clearance can push you past the tipping point. This also helps explain why two people on the same diuretic at the same dose can have such different outcomes: one develops gout within months while the other never does.

Genetic testing for gout susceptibility isn’t standard clinical practice yet, but understanding that the risk has a genetic component can be useful. If you have a strong family history of gout, that information should factor into the conversation about which blood pressure medication to start. It’s another reason to lean toward losartan or a calcium channel blocker when the clinical situation allows it, rather than defaulting to a diuretic.

Practical Steps If You’re Concerned

If you’re taking blood pressure medication and either have gout or worry about it, there are concrete things to do beyond just hoping for the best.

Check your medication: Ask your doctor or pharmacist which class your blood pressure drug falls into. Diuretics and beta-blockers carry the most gout risk. If you’re on a combination pill, a diuretic may be embedded in it without your realizing.
Ask about switching: If gout is active or uric acid is elevated, losartan and calcium channel blockers are reasonable alternatives for many people. The switch isn’t always possible, especially if you have heart failure or fluid retention, where diuretics are harder to replace.
Monitor uric acid: A simple blood test can track your levels over time. If you start a diuretic and uric acid climbs above 6-7 mg/dL, that’s a conversation worth having before a gout flare happens.
Consider dose: Lower doses of thiazide diuretics carry less gout risk than higher doses. If you’re on 25 mg or more and your blood pressure could be managed at a lower dose or with an added second agent, that adjustment might meaningfully reduce your risk.
Don’t stop medications on your own: Uncontrolled hypertension causes strokes, heart attacks, and kidney failure. Gout is painful and potentially joint-damaging, but it’s treatable. Stopping blood pressure medication without a replacement plan is far more dangerous than the gout risk.

When Diuretics Can’t Be Avoided

Some people genuinely need diuretics. Heart failure patients often depend on them to prevent dangerous fluid overload. People with resistant hypertension that doesn’t respond to other classes may require a thiazide or thiazide-like agent. In these situations, the answer isn’t to forgo the diuretic but to manage the downstream effect on uric acid.

Urate-lowering drugs like allopurinol are effective even in the presence of diuretics, though reaching the lowest uric acid targets may take more effort.¹⁶ Adding losartan to a diuretic-based regimen makes sense for dual benefit: the losartan handles some of the blood pressure load while partially counteracting the uric acid rise from the diuretic. This combination gets recommended often in rheumatology and cardiology guidelines for exactly this population.¹⁷

Lifestyle adjustments also help stack the odds. Reducing alcohol intake, limiting high-purine foods like organ meats and certain seafood, staying hydrated, and maintaining a healthy weight all lower uric acid independently of medication. None of these alone will overcome a strong medication-driven rise in uric acid, but they can be the difference between staying just below and just above the crystallization threshold.

1
PubMed. Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study
2
PubMed. Cardiovascular drugs and serum uric acid
3
PubMed Central. Diuretic use, increased serum urate levels, and risk of incident gout in a population-based study of adults with hypertension: the Atherosclerosis Risk in Communities cohort study
4
PubMed. Use of diuretics and risk of incident gout: a population-based case-control study
5
Frontiers in Pharmacology. Hyperuricaemia, gout and related adverse events associated with antihypertensive drugs: A real-world analysis using the FDA adverse event reporting system
6
PubMed Central. Comparison of new-onset gout in adults prescribed chlorthalidone vs. hydrochlorothiazide for hypertension
7
Journal of Clinical Epidemiology. Thiazide diuretics and the initiation of anti-gout therapy
8
PubMed Central. Metoprolol Increases Uric Acid and Risk of Gout in African Americans With Chronic Kidney Disease Attributed to Hypertension
9
PubMed Central. The Effects of Antihypertensive Class on Gout in Older Adults: Secondary Analysis of the ALLHAT Trial
10
PubMed. Hyperuricemia and Gout: The Role of Losartan
11
PubMed. Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout
12
PubMed. Serum uric acid change in relation to antihypertensive therapy with the dihydropyridine calcium channel blockers
13
PubMed. Investigation of the causal effects of hypertension, candesartan, lisinopril, and ramipril on gout
14
PubMed Central. Alcohol quantity and type on risk of recurrent gout attacks: An internet-based case-crossover study
15
PubMed. Purine-rich foods intake and recurrent gout attacks
16
PubMed Central. Impact of diuretics on the urate lowering therapy in patients with gout: analysis of an inception cohort
17
Current Opinion in Rheumatology. Hypertension, its treatment, hyperuricaemia and gout
18
PubMed Central. A urate gene-by-diuretic interaction and gout risk in participants with hypertension: results from the ARIC study